SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T - Tender offer statement by Third Party:
SEC Accession No. 0001140361-24-001546
Filing Date
2024-01-09
Accepted
2024-01-10 08:51:27
Documents
14
Group Members
CONCENTRA BIOSCIENCES, LLCTANG CAPITAL MANAGEMENT, LLCTANG CAPITAL PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 SC TO-T ny20018184x1_sctot.htm SC TO-T 93465
2 EXHIBIT 99.(A)(1)(A) ny20018184x1_exa1a.htm EX-99.(A)(1)(A) 608549
3 EXHIBIT 99.(A)(1)(B) ny20018184x1_exa1b.htm EX-99.(A)(1)(B) 133383
4 EXHIBIT 99.(A)(1)(C) ny20018184x1_exa1c.htm EX-99.(A)(1)(C) 22831
5 EXHIBIT 99.(A)(1)(D) ny20018184x1_exa1d.htm EX-99.(A)(1)(D) 40341
6 EXHIBIT 99.(D)(2) ny20018184x1_exd2.htm EX-99.(D)(2) 47740
7 EXHIBIT 99.(D)(4) ny20018184x1_exd4.htm EX-99.(D)(4) 44675
8 FILING FEES TABLE ny20018184x1_ex107.htm EX-FILING FEES 13396
9 ny20018184x1_form01.jpg GRAPHIC 1190025
10 ny20018184x1_form02.jpg GRAPHIC 1617609
11 ny20018184x1_form03.jpg GRAPHIC 1247553
12 ny20018184x1_form04.jpg GRAPHIC 1399083
13 ny20018184x1_form05.jpg GRAPHIC 1198350
14 ny20018184x1_form06.jpg GRAPHIC 463823
  Complete submission text file 0001140361-24-001546.txt   10806597
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Subject) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T | Act: 34 | File No.: 005-92944 | Film No.: 24524965
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 8582003830
Concentra Merger Sub II, Inc. (Filed by) CIK: 0002004484 (see all company filings)

IRS No.: 934813439 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T